Search Results - "Floquet, Anne"

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial by Swisher, Elizabeth M, Dr Prof, Lin, Kevin K, PhD, Oza, Amit M, Prof, Scott, Clare L, PhD, Giordano, Heidi, MA, Sun, James, PhD, Konecny, Gottfried E, MD, Coleman, Robert L, Prof, Tinker, Anna V, MD, O'Malley, David M, MD, Kristeleit, Rebecca S, MD, Ma, Ling, MD, Bell-McGuinn, Katherine M, MD, Brenton, James D, Prof, Cragun, Janiel M, MD, Oaknin, Ana, MD, Ray-Coquard, Isabelle, Prof, Harrell, Maria I, PhD, Mann, Elaina, MS, Kaufmann, Scott H, Prof, Floquet, Anne, MD, Leary, Alexandra, MD, Harding, Thomas C, PhD, Goble, Sandra, MS, Maloney, Lara, BA, Isaacson, Jeff, PhD, Allen, Andrew R, MD, Rolfe, Lindsey, MBChB, Yelensky, Roman, PhD, Raponi, Mitch, PhD, McNeish, Iain A, Prof

“…Summary Background Poly(ADP-ribose) polymerase (PARP) inhibitors have activity in ovarian carcinomas with homologous recombination deficiency. Along with BRCA1…”
Get full text

Applying Ostrom’s institutional analysis and development framework to soil and water conservation activities in north-western Ethiopia by Nigussie, Zerihun, Tsunekawa, Atsushi, Haregeweyn, Nigussie, Adgo, Enyew, Cochrane, Logan, Floquet, Anne, Abele, Steffen

“…Sustainable land management is of utmost importance in Ethiopia and relies on Soil and Water Conservation (SWC) measures collectively implemented by…”
Get full text

Incorporation of pazopanib in maintenance therapy of ovarian cancer by du Bois, Andreas, Floquet, Anne, Kim, Jae-Weon, Rau, Joern, del Campo, Josep M, Friedlander, Michael, Pignata, Sandro, Fujiwara, Keiichi, Vergote, Ignace, Colombo, Nicoletta, Mirza, Mansoor R, Monk, Bradley J, Kimmig, Rainer, Ray-Coquard, Isabelle, Zang, Rongyu, Diaz-Padilla, Ivan, Baumann, Klaus H, Mouret-Reynier, Marie-Ange, Kim, Jae-Hoon, Kurzeder, Christian, Lesoin, Anne, Vasey, Paul, Marth, Christian, Canzler, Ulrich, Scambia, Giovanni, Shimada, Muneaki, Calvert, Paula, Pujade-Lauraine, Eric, Kim, Byoung-Gie, Herzog, Thomas J, Mitrica, Ionel, Schade-Brittinger, Carmen, Wang, Qiong, Crescenzo, Rocco, Harter, Philipp

“…Pazopanib is an oral, multikinase inhibitor of vascular endothelial growth factor receptor (VEGFR) -1/-2/-3, platelet-derived growth factor receptor (PDGFR)…”
Get full text

Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms by Croce, Sabrina, Hostein, Isabelle, Longacre, Teri A., Mills, Anne M., Pérot, Gaëlle, Devouassoux-Shisheboran, Mojgan, Velasco, Valérie, Floquet, Anne, Guyon, Frédéric, Chakiba, Camille, Querleu, Denis, Khalifa, Emmanuel, Mayeur, Laetitia, Rebier, Flora, Leguellec, Sophie, Soubeyran, Isabelle, McCluggage, W. Glenn

“…Mesenchymal neoplasms of the uterus (corpus and cervix) encompass a heterogeneous group of tumors with differing morphologies, immunophenotypes and molecular…”
Get full text

Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer by SOUBEYRAN, Pierre, FONCK, Marianne, ANDRIAMAMPIONONA, Francis, HOUEDE, Nadine, FLOQUET, Anne, CHOMY, Francois, BROUSTE, Veronique, RAVAUD, Alain, BELLERA, Carine, RAINFRAY, Muriel, BLANC-BISSON, Christèle, BLANC, Jean-Frédéric, CECCALDI, Joel, MERTENS, Cécile, IMBERT, Yves, CANY, Laurent, VOGT, Luc, DAUBA, Jerôme

“…Objective factors for making choices about the treatment of elderly patients with cancer are lacking. This investigation aimed to help physicians select…”
Get full text

Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group by Freyer, Gilles, Floquet, Anne, Tredan, Olivier, Carrot, Aurore, Langlois-Jacques, Carole, Lopez, Jonathan, Selle, Frédéric, Abdeddaim, Cyril, Leary, Alexandra, Dubot-Poitelon, Coraline, Fabbro, Michel, Gladieff, Laurence, Lamuraglia, Michele

“…Most patients with advanced ovarian cancer (AOC) ultimately relapse after platinum-based chemotherapy. Combining bevacizumab, olaparib, and durvalumab likely…”
Get full text

Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial by Rouzier, Roman, Gouy, Sébastien, Selle, Frédéric, Lambaudie, Eric, Floquet, Anne, Fourchotte, Virginie, Pomel, Christophe, Colombo, Pierre-Emmanuel, Kalbacher, Elsa, Martin-Francoise, Sandrine, Fauvet, Raffaele, Follana, Philippe, Lesoin, Anne, Lecuru, Fabrice, Ghazi, Youssef, Dupin, Julien, Chereau, Elisabeth, Zohar, Sarah, Cottu, Paul, Joly, Florence

“…Abstract Aim To investigate whether adding bevacizumab to neoadjuvant carboplatin-paclitaxel (CP) helps achieve optimal debulking, measured by complete…”
Get full text

Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group by Freyer, Gilles, Floquet, Anne, Tredan, Olivier, Carrot, Aurore, Langlois-Jacques, Carole, Lopez, Jonathan, Selle, Frédéric, Abdeddaim, Cyril, Leary, Alexandra, Dubot-Poitelon, Coraline, Fabbro, Michel, Gladieff, Laurence, Lamuraglia, Michele

Get full text

Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy by HOPPE, Stéphanie, RAINFRAY, Muriel, VOGT, Luc, DAUBA, Jérôme, HOUEDE, Nadine, BELLERA, Carine A, FLOQUET, Anne, FABRY, Marie-Noëlle, RAVAUD, Alain, CHAKIBA, Camille, MATHOULIN-PELISSIER, Simone, SOUBEYRAN, Pierre, FONCK, Marianne, HOPPENREYS, Laurent, BLANC, Jean-Frédéric, CECCALDI, Joël, MERTENS, Cécile, BLANC-BISSON, Christèle, IMBERT, Yves, CANY, Laurent

“…To determine factors associated with early functional decline during first-line chemotherapy in older patients. Patients age ≥ 70 years receiving first-line…”
Get full text

MED12 alterations in both human benign and malignant uterine soft tissue tumors by Pérot, Gaëlle, Croce, Sabrina, Ribeiro, Agnès, Lagarde, Pauline, Velasco, Valérie, Neuville, Agnès, Coindre, Jean-Michel, Stoeckle, Eberhard, Floquet, Anne, MacGrogan, Gaëtan, Chibon, Frédéric

“…The relationship between benign uterine leiomyomas and their malignant counterparts, i.e. leiomyosarcomas and smooth muscle tumors of uncertain malignant…”
Get full text

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial by Pautier, Patricia, Dr, Floquet, Anne, MD, Chevreau, Christine, MD, Penel, Nicolas, MD, Guillemet, Cécile, MD, Delcambre, Corinne, MD, Cupissol, Didier, MD, Selle, Frédéric, MD, Isambert, Nicolas, MD, Piperno-Neumann, Sophie, MD, Thyss, Antoine, Prof, Bertucci, François, Prof, Bompas, Emmanuelle, MD, Alexandre, Jerôme, Prof, Collard, Olivier, MD, Lavau-Denes, Sandrine, MD, Soulié, Patrick, MD, Toulmonde, Maud, MD, Le Cesne, Axel, MD, Lacas, Benjamin, MSc, Duffaud, Florence, Prof

“…Summary Background Metastatic leiomyosarcomas of uterine or soft-tissue origin have poor prognosis and moderate chemosensitivity. Trabectedin has shown…”
Get full text

Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors by Croce, Sabrina, Ducoulombier, Agnès, Ribeiro, Agnès, Lesluyes, Tom, Noel, Jean-Christophe, Amant, Frédéric, Guillou, Louis, Stoeckle, Eberhard, Devouassoux-Shisheboran, Mojgan, Penel, Nicolas, Floquet, Anne, Arnould, Laurent, Guyon, Frédéric, Mishellany, Florence, Chakiba, Camille, Cuppens, Tine, Zikan, Michal, Leroux, Agnès, Frouin, Eric, Farre, Isabelle, Genestie, Catherine, Valo, Isabelle, MacGrogan, Gaëtan, Chibon, Frédéric

“…The diagnosis of a uterine smooth muscle lesion is, in the majority of cases, straightforward. However, in a small number of cases, the morphological criteria…”
Get full text

HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial by Fabbro, Michel, Lamy, Pierre-Jean, Touraine, Célia, Floquet, Anne, Ray-Coquard, Isabelle, Mollevi, Caroline

“…HE4 and CA-125 are used for epithelial ovarian cancer (EOC) screening, diagnosis, and follow-up. Our objective was to study HE4 and CA-125 kinetics in patients…”
Get full text

Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions by Croce, Sabrina, Ribeiro, Agnes, Brulard, Celine, Noel, Jean-Christophe, Amant, Frederic, Stoeckle, Eberhard, Devouassoux-Shisheborah, Mojgan, Floquet, Anne, Arnould, Laurent, Guyon, Frederic, Mishellany, Florence, Garbay, Delphine, Cuppens, Tine, Zikan, Michal, Leroux, Agnès, Frouin, Eric, Duvillard, Pierre, Terrier, Philippe, Farre, Isabelle, Valo, Isabelle, MacGrogan, Gaetan M, Chibon, Frederic

“…The diagnosis and management of uterine smooth muscle tumors with uncertain malignant potential (STUMP) is often challenging, and genomic data on these lesions…”
Get full text

Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma by Amant, Frédéric, Floquet, Anne, Friedlander, Michael, Kristensen, Gunnar, Mahner, Sven, Nam, Eun Ji, Powell, Matthew A, Ray-Coquard, Isabelle, Siddiqui, Nadeem, Sykes, Peter, Westermann, Anneke M, Seddon, Beatrice

“…Endometrial stromal sarcoma (ESS) accounts for approximately 20% of all uterine sarcomas and presents, at a mean age, around 50 years of age. Half of the…”
Get more information

Tacit knowledge acquisition and incremental innovation capability: Proximity perspective by Houessou, Albertine M., Aoudji, Augustin K.N., Biaou, Gauthier, Floquet, Anne

“…Knowledge, especially tacit knowledge (TK), has become the most strategic resource for firms' innovativeness and competitiveness. However, most agricultural…”
Get full text

Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers by Cottu, Paul H, Bonneterre, Jacques, Varga, Andrea, Campone, Mario, Leary, Alexandra, Floquet, Anne, Berton-Rigaud, Dominique, Sablin, Marie-Paule, Lesoin, Anne, Rezai, Keyvan, Lokiec, François M, Lhomme, Catherine, Bosq, Jacques, Bexon, Alice S, Gilles, Erard M, Proniuk, Stefan, Dieras, Veronique, Jackson, David M, Zukiwski, Alexander, Italiano, Antoine

“…Onapristone is a type I progesterone receptor (PR) antagonist, which prevents PR- mediated DNA transcription. Onapristone is active in multiple preclinical…”
Get full text

PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients by de la Rochefordiere, Anne, Kamal, Maud, Floquet, Anne, Thomas, Laurence, Petrow, Peter, Petit, Thierry, Pop, Marius, Fabbro, Michel, Kerr, Christine, Joly, Florence, Sevin, Emmanuel, Maillard, Sophie, Curé, Hervé, Weber, Béatrice, Brunaud, Claire, Minsat, Mathieu, Gonzague, Laurence, Berton-Rigaud, Dominique, Aumont, Maud, Gladieff, Laurence, Peignaux, Karine, Bernard, Virginie, Leroy, Quentin, Bieche, Ivan, Margogne, Audrey, Nadan, AnaTereza, Fourchotte, Virginie, Diallo, Alhassane, Asselain, Benard, Plancher, Corine, Armanet, Sébastien, Beuzeboc, Philippe, Scholl, Suzy M

“…EGFR is frequently overexpressed in cervical cancer, suggesting EGFR blockade as a promising treatment approach. Cetuximab, an anti EGFR antibody, used…”
Get full text

"Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors" by Gernier, François, Ahmed-Lecheheb, Djihane, Pautier, Patricia, Floquet, Anne, Nadeau, Cédric, Frank, Sophie, Alexandre, Jérôme, Selle, Frédéric, Berton-Rigaud, Dominique, Kalbacher, Elsa, Orfeuvre, Hubert, Lortholary, Alain, Augereau, Paule, Labombarda, Fabien, Perrier, Lionel, Grellard, Jean-Michel, Licaj, Idlir, Clarisse, Bénédicte, Savoye, Aude-Marie, Bourien, Héloise, De La Motte Rouge, Thibaut, Kurtz, Jean-Emmanuel, Kerdja, Katia, Lelaidier, Anaïs, Charreton, Amandine, Ray-Coquard, Isabelle, Joly, Florence

“…Germ cell tumors and sex cord stromal tumors are rare cancers of the ovary. They mainly affect young women and are associated with a high survival rate. The…”
Get full text

Market opportunities seizing capability and fish farming firm performance: A dynamic managerial capability perspective by Houessou, Albertine M., Aoudji, Augustin K.N., Biaou, Gauthier, Floquet, Anne

“…The role that owner-managers’ managerial capabilities play in agricultural firms' strategic change and performance is still unclear. A firm's market…”
Get full text